Q3 2024 Earnings Call Transcript November 13, 2024 Operator: Good day, and welcome to the ARS Pharmaceuticals Third Quarter ...

Commercial launch of neffy®(epinephrine nasal spray) underway in the United StatesSupplemental NDA for neffy®1mg dose granted priority review by ...

Short interest in ARS Pharmaceuticals Inc (NASDAQ:SPRY) increased during the last reporting period, rising from 11.92M to 12.60M. This put 24.49% of the company's publicly available shares short.

However, nausea and vomiting during attacks may limit the usefulness of oral medications. An alternative, nasal spray, formulation has been developed that demonstrates good efficacy, high ...

And ignoring it won’t make it go away. Dentists I’ve spoken to as the Strategist’s dental-hygiene writer have told me it can lead to serious oral issues, including loss of enamel ...

Commercial launch of neffy® (epinephrine nasal spray) underway in the United StatesSupplemental NDA for neffy®1mg dose granted priority review by FDA; PDUFA target date set for March 6, 2025Exclusive ...

This advertisement has not loaded yet, but your article continues below. Images of the tests showed what appeared to be a BMW sedan being destroyed and old models of tanks being blown up More than ...